Department of Public Health, School of Health Sciences, University of Brasília, Brasília, Brazil
Commentary
Infliximab vs. Other Biologics: A Comparative Study in Autoimmune Treatment
Author(s): Feira Nishee*
DOI:
10.37421/2476-1958.2024.9.221
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 